Patents by Inventor Tsun-Yuan Lin

Tsun-Yuan Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12194015
    Abstract: The present invention provides a composition, comprising ferrous amino acid chelate particles sintered from ferrous amino acid chelate, wherein the average particle size of the ferrous amino acid chelate particles ranges from 500 nm to 2600 nm, and the average molecular weight of the particles ranges from 1,500 Dalton to 600,000 Dalton. Besides, the present invention can be used for manufacturing a medicament for treating or ameliorating a pancreas-related disease, wherein the medicament comprises an effective amount of the composition and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: January 14, 2025
    Assignee: PROFEAT BIOTECHNOLOGY CO., LTD.
    Inventors: Tsun-Yuan Lin, Mu-Kuei Chen, Tsang-Tse Chen, Hsun-Jin Jan, Chai-Hui Fu, Kai-Ting Wang
  • Publication number: 20220031651
    Abstract: The present invention provides a composition, comprising ferrous amino acid chelate particles sintered from ferrous amino acid chelate, wherein the average particle size of the ferrous amino acid chelate particles ranges from 500 nm to 2600 nm, and the average molecular weight of the particles ranges from 1,500 Dalton to 600,000 Dalton. Besides, the present invention can be used for manufacturing a medicament for treating or ameliorating a pancreas-related disease, wherein the medicament comprises an effective amount of the composition and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 20, 2018
    Publication date: February 3, 2022
    Inventors: Tsun-Yuan LIN, Mu-Kuei CHEN, Tsang-Tse CHEN, Hsun-Jin JAN, Chai-Hui FU, Kai-Ting WANG
  • Patent number: 11141382
    Abstract: A composition includes sintered nanoparticles prepared by sintering a chelate of ferrous ions with an amino acid. The sintered nanoparticles have an average particle diameter ranging from 10 to 400 nm as determined by Electron Probe X-ray Micro-Analyzer. Also disclosed herein are a method for inhibiting and/or killing a virus in a subject and applications of such method. The method includes administering to the subject the composition.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: October 12, 2021
    Assignee: PROFEAT BIOTECHNOLOGY CO., LTD.
    Inventors: Tsun-Yuan Lin, Mu-Kuei Chen, Kai-Ting Wang, Hsun-Jin Jan
  • Patent number: 11110065
    Abstract: A composition includes sintered ferrous amino acid particles prepared by sintering a ferrous amino acid chelate which includes ferrous ions and an amino acid. The sintered ferrous amino acid particles have an average particle size ranging from 500 to 2600 nm and a weight average molecular weight ranging from 1,500 Dalton to 600,000 Dalton. Also disclosed herein are a method for inhibiting and/or killing a virus in a subject and applications of such method. The method includes administering to the subject the composition.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: September 7, 2021
    Assignee: PROFEAT BIOTECHNOLOGY CO., LTD.
    Inventors: Tsun-Yuan Lin, Mu-Kuei Chen, Kai-Ting Wang, Hsun-Jin Jan
  • Patent number: 10881621
    Abstract: A composition includes sintered ferrous amino acid particles prepared by sintering a ferrous amino acid chelate which includes ferrous ions and an amino acid. The sintered ferrous amino acid particles have an average particle size ranging from 500 to 2600 nm and a weight average molecular weight ranging from 1,500 Dalton to 600,000 Dalton. Also disclosed herein are a method for inhibiting and/or killing a virus in a subject and applications of such method. The method includes administering to the subject the composition.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: January 5, 2021
    Assignee: PROFEAT BIOTECHNOLOGY CO., LTD.
    Inventors: Tsun-Yuan Lin, Mu-Kuei Chen, Kai-Ting Wang, Hsun-Jin Jan
  • Patent number: 10813906
    Abstract: Disclosed herein is a method for treating infection by an enteropathogen and/or enhancing growth performance, which includes administering to a subject in need thereof a composition containing a ferrous amino acid chelate. Also disclosed herein is an animal feed containing the ferrous amino acid chelate.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: October 27, 2020
    Assignee: PROFEAT BIOTECHNOLOGY CO., LTD.
    Inventors: Tsun-Yuan Lin, Mu-Kuei Chen, Kai-Ting Wang, Hsun-Jin Jan
  • Publication number: 20200316113
    Abstract: The present invention is related to a use of a composition comprising ferrous amino acid chelate for the manufacture of a medicament for inhibiting angiogenesis, wherein the medicament comprises an effective amount of the ferrous amino acid chelate composition and a pharmaceutically acceptable carrier. The amino acid can be glycine and the angiogenesis can be related to cancer or eye disease.
    Type: Application
    Filed: December 29, 2017
    Publication date: October 8, 2020
    Inventors: Tsun-Yuan LIN, Mu-Kuei CHEN, Hsun-Jin JAN, Chai-Hui FU
  • Patent number: 10702494
    Abstract: The present invention is related to a method for cancer treatment comprising a step of administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising ferrous amino acid chelate and a pharmaceutically acceptable carrier. By means of amino acid chelating to ferrous and maintaining chelating state through the stomach, the pharmaceutical composition in accordance with the present invention would not cause any weight variation, and is suitable for inhibiting or treating cancer.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: July 7, 2020
    Assignee: Profeat Biotechnology Co., Ltd.
    Inventors: Tsun-Yuan Lin, Mu-Kuei Chen, Tsang-Tse Chen, Chai-Hui Fu, Hsun-Jin Jan, Wen-Cheng Chiu
  • Publication number: 20200138726
    Abstract: A composition includes sintered nanoparticles prepared by sintering a chelate of ferrous ions with an amino acid. The sintered nanoparticles have an average particle diameter ranging from 10 to 400 nm as determined by Electron Probe X-ray Micro-Analyzer. Also disclosed herein are a method for inhibiting and/or killing a virus in a subject and applications of such method. The method includes administering to the subject the composition.
    Type: Application
    Filed: December 27, 2019
    Publication date: May 7, 2020
    Inventors: Tsun-Yuan LIN, Mu-Kuei CHEN, Kai-Ting WANG, Hsun-Jin JAN
  • Publication number: 20190365697
    Abstract: The present invention provides use of a composition comprising ferrous amino acid chelate for the manufacture of a medicament for treatment of liver dysfunction, wherein the medicament comprises an effective amount of the ferrous amino acid chelate composition and a pharmaceutically acceptable carrier. The present invention proves that the serum biochemistry values related to the liver function can be reduced by administering the composition comprising ferrous amino acid chelate. For animals whose liver functions cannot be improved by long-term administration of S-adenosylmethionine, their liver functions can be effectively improved by administration of the composition comprising ferrous amino acid chelate of the present invention instead. Furthermore, the composition comprising ferrous amino acid chelate can improve the functions of an aged liver.
    Type: Application
    Filed: February 17, 2017
    Publication date: December 5, 2019
    Inventors: Kai-Ting WANG, Tsun-Yuan LIN, Mu-Kuei CHEN, Hsun-Jin JAN
  • Publication number: 20190358168
    Abstract: A composition includes sintered ferrous amino acid particles prepared by sintering a ferrous amino acid chelate which includes ferrous ions and an amino acid. The sintered ferrous amino acid particles have an average particle size ranging from 500 to 2600 nm and a weight average molecular weight ranging from 1,500 Dalton to 600,000 Dalton. Also disclosed herein are a method for inhibiting and/or killing a virus in a subject and applications of such method. The method includes administering to the subject the composition.
    Type: Application
    Filed: July 31, 2019
    Publication date: November 28, 2019
    Inventors: Tsun-Yuan LIN, Mu-Kuei CHEN, Kai-Ting WANG, Hsun-Jin JAN
  • Publication number: 20190314322
    Abstract: Disclosed herein is a method for treating infection by an enteropathogen and/or enhancing growth performance, which includes administering to a subject in need thereof a composition containing a ferrous amino acid chelate. Also disclosed herein is an animal feed containing the ferrous amino acid chelate.
    Type: Application
    Filed: December 20, 2018
    Publication date: October 17, 2019
    Inventors: Tsun-Yuan LIN, Mu-Kuei CHEN, Kai-Ting WANG, Hsun-Jin JAN
  • Publication number: 20190274967
    Abstract: A composition includes sintered ferrous amino acid particles prepared by sintering a ferrous amino acid chelate which includes ferrous ions and an amino acid. The sintered ferrous amino acid particles have an average particle size ranging from 500 to 2600 nm and a weight average molecular weight ranging from 1,500 Dalton to 600,000 Dalton. Also disclosed herein are a method for inhibiting and/or killing a virus in a subject and applications of such method. The method includes administering to the subject the composition.
    Type: Application
    Filed: December 18, 2018
    Publication date: September 12, 2019
    Inventors: Tsun-Yuan LIN, Mu-Kuei CHEN, Kai-Ting WANG, Hsun-Jin JAN
  • Patent number: 10183040
    Abstract: Provided is a method for regulation of lipid metabolism comprising a step of administering to a subject in need thereof a therapeutically amount of pharmaceuticals. The pharmaceuticals comprise an effective amount of a composition containing a ferrous amino acid chelate and pharmaceutically acceptable carriers to regulate lipid metabolism. The amino acid is capable of being chelated with the ferrous iron in a chelated state stably as passing through a stomach. The composition containing the ferrous amino acid chelate can effectively control the variances of body weight and enhance metabolism of body fat of a subject. The pharmaceuticals prepared by the composition containing the ferrous amino acid chelate have effects on regulation of lipid metabolism.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: January 22, 2019
    Inventors: Tsun-Yuan Lin, Hsun-Jin Jan, Chai-Hui Fu, Tsang-Tse Chen, Mu-Kuei Chen, Horng-Mo Lee
  • Publication number: 20170224727
    Abstract: Provided is a method for regulation of lipid metabolism comprising a step of administering to a subject in need thereof a therapeutically amount of pharmaceuticals. The pharmaceuticals comprise an effective amount of a composition containing a ferrous amino acid chelate and pharmaceutically acceptable carriers to regulate lipid metabolism. The amino acid is capable of being chelated with the ferrous iron in a chelated state stably as passing through a stomach. The composition containing the ferrous amino acid chelate can effectively control the variances of body weight and enhance metabolism of body fat of a subject. The pharmaceuticals prepared by the composition containing the ferrous amino acid chelate have effects on regulation of lipid metabolism.
    Type: Application
    Filed: December 1, 2014
    Publication date: August 10, 2017
    Inventors: Tsun-Yuan LIN, Hsun-Jin JAN, Chai-Hui FU, Tsang-Tse CHEN, Mu-Kuei CHEN, Horng-Mo LEE
  • Publication number: 20170007568
    Abstract: The present invention provides a use of a composition containing a ferrous amino acid chelate for the preparation of a pharmaceutical used in diabetes improvement. The pharmaceutical comprise an effective amount of the composition containing the ferrous amino acid chelate and pharmaceutically acceptable carriers to improve diabetes. The amino acid is able to be chelated with the ferrous iron in a chelated state stably as passing through the stomach. The composition containing the ferrous amino acid chelate can effectively lower blood glucose and improve insulin sensitivity. The pharmaceutical prepared by the composition containing the ferrous amino acid chelate have effect on diabetes improvement.
    Type: Application
    Filed: November 25, 2014
    Publication date: January 12, 2017
    Inventors: Tsun-Yuan LIN, Hsun-Jin JAN, Chai-Hui FU, Tsang-Tse CHEN, Mu-Kuei CHEN, Horng-Mo LEE
  • Publication number: 20150065569
    Abstract: The present invention is related to a method for cancer treatment comprising a step of administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising ferrous amino acid chelate and a pharmaceutically acceptable carrier. By means of amino acid chelating to ferrous and maintaining chelating state through the stomach, the pharmaceutical composition in accordance with the present invention would not cause any weight variation, and is suitable for inhibiting or treating cancer.
    Type: Application
    Filed: September 3, 2014
    Publication date: March 5, 2015
    Inventors: Tsun-Yuan Lin, Mu-Kuei Chen, Tsang-Tse Chen, Chai-Hui Fu, Hsun-Jin Jan, Wen-Cheng Chiu